EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer have?

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer has 372 citations in the OpenAlex counts ScholarIQ stores.

When was EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer published?

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer has 2019 year in the ScholarIQ index.

What is the open-access status of EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer?

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer has bronze oa status in the ScholarIQ index.

What is the DOI of EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer?

The DOI for EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer is on the source record.

What is the PMID of EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer?

The PMID for EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer is on the source record.

What is the OpenAlex record for EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer?

The OpenAlex for EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer is on the source record.